NLI EV/EBIT NL
Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2012.
- Today, Oct 23, 2026
- 16.2×
- 9-year median
- 18.0×
- Against its 9-year history
- 44th
- percentile: 0 is its lowest day, 100 its highest
- 9-year range
- 0.4× to 472×
- Peer median
- 8.9×
NLI's EV/EBIT is 16.2× as of Oct 23, 2026.
That is below its 9-year median of 18.0×, close to the middle of its last 9 years.
Over that time it ranged from 0.4× in Mar 2020 to 472× in Oct 2017.
The median for 6 specialty chemicals stocks of a similar size is 8.9×.
EV/EBIT over time
The dashed line is the 9-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 16.2× | 4.4× | 24.9× |
| 2025 | 4.4× | 4.4× | 30.0× |
| 2024 | 29.2× | 9.6× | 30.8× |
| 2023 | 12.8× | 8.2× | 20.6× |
| 2022 | 17.8× | 16.5× | 32.9× |
| 2021 | 26.1× | 18.4× | 124× |
| 2020 | 24.7× | 0.4× | 28.5× |
| 2019 | 7.3× | 4.0× | 82.0× |
| 2018 | 28.3× | 24.2× | 268× |
| 2017 | 264× | 216× | 472× |
| 2016 | 188× | 11.3× | 255× |
| 2015 | 30.2× | 9.7× | 116× |
| 2014 | 56.9× | 53.4× | 59.6× |
| 2013 | 51.1× | 14.2× | 60.0× |
| 2012 | 45.1× | 44.1× | 52.9× |
Against its peers
Companies in Chemicals - Specialty nearest NLI's size, closest first, today.
| Company | EV/EBIT |
|---|---|
| NLNLI | 16.2× |
| ALTOAlto Ingredients | 9.0× |
| LXFRLuxfer | 22.3× |
| LXULSB Industries | 15.0× |
| WLKPWestlake Chemical Partners | 3.1× |
| GPREGreen Plains | 8.8× |
| REXREX AMERICAN RESOURCES | 7.7× |
| Peer median | 8.9× |
Where NLI ranks
What the EV/EBIT tells you
What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.
Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.
More on NLI
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.